• cheap ms project 2003 buy adobe after effects cs6 abbyy finereader discount best price office 2013 home and business price windows xp home edition discount microsoft office 2003 student nikon capture nx 2 purchase cheap office 2013 downloads buy encarta kids buy adobe dreamweaver cs4 software hire purchase act 2010 malaysia microsoft office 2003 discount cheapest microsoft word download buy corel ventura cheap word 2007
  • cheap adobe fireworks cs3 price of visio software buy photoshop cs3 for mac buy microsoft expression web 2 cheap buy microsoft office onenote 2007 online cheapest microsoft office 2011 student discount windows 7 for 30 price of premiere elements 8 adobe com cost of windows xp cd cheap mathcad 14 buy dreamweaver cs4 cheap buy windows server 2003 standard edition cost of solidworks standard buy microsoft office 2007 standard edition online office 2007 ultimate price

    Chicago ENT head and neck surgeons using VELscope Vx to enhance oral cancer surgery success rate

    Thu, Jan 10, 2013

    Oral Cancer News

    Source: www.menafn.com
    Author: press release

    LED Medical Diagnostics Inc. subsidiary LEDDental announced today that its VELscope Vx enhanced oral assessmentdevice will now be used by Chicago Otolaryngology Associates for oralmucosal abnormality assessment and when performing surgery on oral cancer patients.

    According to Chicago Otolaryngology Associates’ Howard Kotler, MD,FACS, “We pride ourselves on embracing state-of-the-art technologies that allow us to provide the best patient care possible. The VELscopeVx may significantly enhance our ability to see the entire cancerous or precancerous lesion that needs to be excised, allowing us to minimize risk of additional unnecessary surgery.”

    The VELscope Vx’s fluorescence visualization technology is the first approved by the FDA and Health Canada to help surgeons determine the surgical margins when excising cancerous and precancerous tissues. The technology is also approved to help dental and medical professionals discover cancerous and precancerous tissue that might not be apparent to the unaided eye.

    The vast majority of the nearly 12,000 VELscope devices in use around the world are used by dental practices. Typically, when a suspicious lesion is detected by a dentist, the patient is referred to an oral surgeon or a periodontist for a surgical biopsy, which is then evaluated by an oral pathologist. If the biopsy sample is determined to be cancerous or precancerous, the patient is usually referred to an ENT head and neck surgeon for consultation and likely excision. VELscope technology was developed to address the problem of detecting all abnormal tissue, including that beneath the surface, as well as making it possible for dentists to discover early stage oral cancer, which requires less invasive treatment and has a significantly higher chance of survival than when the disease is detected in late stages.

    “We applaud Dr. Kotler and Chicago Otolaryngology Associates forbeing one of the first Otolaryngology practices in the U.S. toincorporate VELscope’s potentially life-saving technology,” saidPeter Whitehead, founder and CEO of LED Dental and its parent, LEDMedical Diagnostics Inc. .

    Print Friendly
    Be Sociable, Share!
    , , , , ,

    Leave a Reply

    You must be logged in to post a comment.